Advertisement
Screener

Pluri Inc. (PLUR) Net Income

Pluri Inc. Net Income

Pluri Inc. (PLUR) reported Net Income of -$23.82 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2026-09-10

  • Pluri Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$5.88M.
  • Pluri Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$5.55M.
  • Pluri Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$6.54M.
  • Pluri Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$5.85M.
  • Pluri Inc. net income (loss) attributable to parent for fiscal 2026 was -$23.82M.
  • Pluri Inc. net income (loss) attributable to parent for fiscal 2025 was -$22.58M.
  • Pluri Inc. net income (loss) attributable to parent for fiscal 2022 was -$41.24M.
  • Pluri Inc. net income (loss) attributable to parent for fiscal 2021 was -$49.87M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 6 month as first filedNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2026-06-30-$5.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10
-$11.43M
derived: sum of 2 quarters · filed 2026-09-10
-$17.97M
derived: sum of 3 quarters · filed 2026-09-10
-$23.82M
10-K · filed 2026-09-10
2026-03-31-$5.55M
10-Q · filed 2026-05-14
-$12.09M
derived: sum of 2 quarters · filed 2026-05-14
-$17.94M
10-Q · filed 2026-05-14
-$25.54M
derived: sum of 4 quarters · filed 2026-09-10
2025-12-31-$6.54M
10-Q · filed 2026-02-12
-$12.39M
10-Q · filed 2026-02-12
-$19.99M
derived: sum of 3 quarters · filed 2026-09-10
-$26.14M
derived: sum of 4 quarters · filed 2026-09-10
2025-09-30-$5.85M
10-Q · filed 2025-11-12
-$13.45M
derived: sum of 2 quarters · filed 2026-09-10
-$19.59M
derived: sum of 3 quarters · filed 2026-09-10
-$22.55M
derived: sum of 4 quarters · filed 2026-09-10
2025-06-30-$7.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10
-$13.74M
derived: sum of 2 quarters · filed 2026-09-10
-$16.70M
derived: sum of 3 quarters · filed 2026-09-10
-$22.58M
10-K · filed 2026-09-10
2025-03-31-$6.15M
10-Q · filed 2026-05-14
-$9.10M
derived: sum of 2 quarters · filed 2026-05-14
-$14.98M
10-Q · filed 2026-05-14
$21.52M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$2.96M
10-Q · filed 2026-02-12
-$8.84M
10-Q · filed 2026-02-12
$27.66M
derived: sum of 3 quarters · filed 2026-04-23
$22.37M
derived: sum of 4 quarters · filed 2026-04-23
2024-09-30-$5.88M
10-Q · filed 2025-11-12
$30.62M
derived: sum of 2 quarters · filed 2026-04-23
$25.33M
derived: sum of 3 quarters · filed 2026-04-23
$20.42M
derived: sum of 4 quarters · filed 2026-04-23
2024-06-30$36.50M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-23
$31.21M
derived: sum of 2 quarters · filed 2026-04-23
$26.30M
derived: sum of 3 quarters · filed 2026-04-23
$21.34M
DEF 14A · filed 2026-04-23
-$20.89M
10-K · filed 2024-09-18
2024-03-31-$5.29M
10-Q · filed 2025-05-13
-$10.20M
derived: sum of 2 quarters · filed 2025-05-13
-$15.16M
10-Q · filed 2025-05-13
$35.59M
derived: sum of 4 quarters · filed 2026-04-23
2023-12-31-$4.91M
10-Q · filed 2025-02-11
-$9.87M
10-Q · filed 2025-02-11
$40.88M
derived: sum of 3 quarters · filed 2026-04-23
$33.26M
derived: sum of 4 quarters · filed 2026-04-23
2023-09-30-$4.96M
10-Q · filed 2024-11-12
$45.79M
derived: sum of 2 quarters · filed 2026-04-23
$38.16M
derived: sum of 3 quarters · filed 2026-04-23
$30.05M
derived: sum of 4 quarters · filed 2026-04-23
2023-06-30$50.75M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-23
$43.13M
derived: sum of 2 quarters · filed 2026-04-23
$35.01M
derived: sum of 3 quarters · filed 2026-04-23
$28.89M
DEF 14A · filed 2026-04-23
-$28.32M
10-K · filed 2023-09-12
2023-03-31-$7.62M
10-Q · filed 2024-05-09
-$15.74M
derived: sum of 2 quarters · filed 2024-05-09
-$21.86M
10-Q · filed 2024-05-09
-$30.87M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$8.12M
10-Q · filed 2024-02-12
-$14.24M
10-Q · filed 2024-02-12
-$23.24M
derived: sum of 3 quarters · filed 2024-02-12
-$33.11M
derived: sum of 4 quarters · filed 2024-02-12
2022-09-30-$6.12M
10-Q · filed 2023-11-13
-$15.13M
derived: sum of 2 quarters · filed 2023-11-13
-$24.99M
derived: sum of 3 quarters · filed 2023-11-13
-$35.93M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$9.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12
-$18.87M
derived: sum of 2 quarters · filed 2023-09-12
-$29.81M
derived: sum of 3 quarters · filed 2023-09-12
-$41.24M
10-K · filed 2023-09-12
2022-03-31-$9.87M
10-Q · filed 2023-05-09
-$20.80M
derived: sum of 2 quarters · filed 2023-05-09
-$32.24M
10-Q · filed 2023-05-09
2021-12-31-$10.94M
10-Q · filed 2023-02-13
-$22.37M
10-Q · filed 2023-02-13
2021-12-30-$10.94M
10-Q · filed 2022-02-07
-$22.37M
10-Q · filed 2022-02-07
-$36.94M
derived: sum of 3 quarters · filed 2022-11-10
-$51.19M
derived: sum of 4 quarters · filed 2022-11-10
2021-09-30-$11.43M
10-Q · filed 2022-11-10
-$26.00M
derived: sum of 2 quarters · filed 2022-11-10
-$40.25M
derived: sum of 3 quarters · filed 2022-11-10
-$52.81M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$14.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-21
-$28.82M
derived: sum of 2 quarters · filed 2022-09-21
-$41.38M
derived: sum of 3 quarters · filed 2022-09-21
-$49.87M
10-K · filed 2022-09-21
2021-03-31-$14.25M
10-Q · filed 2022-05-09
-$26.81M
derived: sum of 2 quarters · filed 2022-05-09
-$35.30M
10-Q · filed 2022-05-09
2020-12-31-$12.55M
10-Q · filed 2022-02-07
-$21.04M
10-Q · filed 2022-02-07
2020-12-30-$12.55M
10-Q · filed 2022-02-07
-$21.04M
10-Q · filed 2022-02-07
-$29.18M
derived: sum of 3 quarters · filed 2022-02-07
-$36.69M
derived: sum of 4 quarters · filed 2022-02-07
2020-09-30-$8.49M
10-Q · filed 2021-11-08
-$16.63M
derived: sum of 2 quarters · filed 2021-11-08
-$24.13M
derived: sum of 3 quarters · filed 2021-11-08
-$30.50M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30-$8.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-13
-$15.64M
derived: sum of 2 quarters · filed 2021-09-13
-$22.01M
derived: sum of 3 quarters · filed 2021-09-13
-$29.15M
10-K · filed 2021-09-13
2020-03-31-$7.51M
10-Q · filed 2021-05-06
-$13.88M
derived: sum of 2 quarters · filed 2021-05-06
-$21.02M
10-Q · filed 2021-05-06
-$28.78M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31-$6.37M
10-Q · filed 2021-02-08
-$13.51M
10-Q · filed 2021-02-08
-$21.27M
derived: sum of 3 quarters · filed 2021-02-08
-$31.35M
derived: sum of 4 quarters · filed 2021-02-08
2019-09-30-$7.14M
10-Q · filed 2020-11-05
-$14.90M
derived: sum of 2 quarters · filed 2020-11-05
-$24.98M
derived: sum of 3 quarters · filed 2020-11-05
-$33.66M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$7.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10
-$17.84M
derived: sum of 2 quarters · filed 2020-09-10
-$26.52M
derived: sum of 3 quarters · filed 2020-09-10
-$35.31M
10-K · filed 2020-09-10
2019-03-31-$10.08M
10-Q · filed 2020-05-11
-$18.76M
derived: sum of 2 quarters · filed 2020-05-11
-$27.55M
10-Q · filed 2020-05-11
-$36.53M
derived: sum of 4 quarters · filed 2020-09-10
2018-12-31-$8.68M
10-Q · filed 2020-02-06
-$17.47M
10-Q · filed 2020-02-06
-$26.45M
derived: sum of 3 quarters · filed 2020-09-10
-$27.98M
derived: sum of 4 quarters · filed 2020-09-10
2018-09-30-$8.79M
10-Q · filed 2019-11-07
-$17.77M
derived: sum of 2 quarters · filed 2020-09-10
-$19.30M
derived: sum of 3 quarters · filed 2020-09-10
-$27.53M
derived: sum of 4 quarters · filed 2020-09-10
2018-06-30-$8.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10
-$10.51M
derived: sum of 2 quarters · filed 2020-09-10
-$18.74M
derived: sum of 3 quarters · filed 2020-09-10
-$26.13M
10-K · filed 2020-09-10
2018-03-31-$1.53M
10-Q · filed 2019-05-06
-$9.76M
derived: sum of 2 quarters · filed 2019-05-06
-$17.14M
10-Q · filed 2019-05-06
-$24.16M
derived: sum of 4 quarters · filed 2019-09-12
2017-12-31-$8.23M
10-Q · filed 2019-02-06
-$15.61M
10-Q · filed 2019-02-06
-$22.63M
derived: sum of 3 quarters · filed 2019-09-12
-$30.49M
derived: sum of 4 quarters · filed 2019-09-12
2017-09-30-$7.38M
10-Q · filed 2018-11-07
-$14.40M
derived: sum of 2 quarters · filed 2019-09-12
-$22.27M
derived: sum of 3 quarters · filed 2019-09-12
-$28.88M
derived: sum of 4 quarters · filed 2019-09-12
2017-06-30-$7.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12
-$14.88M
derived: sum of 2 quarters · filed 2019-09-12
-$21.49M
derived: sum of 3 quarters · filed 2019-09-12
-$27.81M
10-K · filed 2019-09-12
2017-03-31-$7.86M
10-Q · filed 2018-05-09
-$14.47M
derived: sum of 2 quarters · filed 2018-05-09
-$20.80M
10-Q · filed 2018-05-09
-$27.00M
derived: sum of 4 quarters · filed 2018-09-12
2016-12-31-$6.61M
10-Q · filed 2018-02-06
-$12.93M
10-Q · filed 2018-02-06
-$19.14M
derived: sum of 3 quarters · filed 2018-09-12
-$26.34M
derived: sum of 4 quarters · filed 2018-09-12
2016-09-30-$6.32M
10-Q · filed 2017-11-07
-$12.53M
derived: sum of 2 quarters · filed 2018-09-12
-$19.73M
derived: sum of 3 quarters · filed 2018-09-12
-$23.69M
derived: sum of 4 quarters · filed 2018-09-12
2016-06-30-$6.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12
-$13.41M
derived: sum of 2 quarters · filed 2018-09-12
-$17.37M
derived: sum of 3 quarters · filed 2018-09-12
-$23.25M
10-K · filed 2018-09-12
2016-03-31-$7.20M
10-Q · filed 2017-05-08
-$11.16M
derived: sum of 2 quarters · filed 2017-05-08
-$17.04M
10-Q · filed 2017-05-08
-$22.34M
derived: sum of 4 quarters · filed 2017-09-07
2015-12-31-$3.96M
10-Q · filed 2017-02-08
-$9.84M
10-Q · filed 2017-02-08
-$15.13M
derived: sum of 3 quarters · filed 2017-09-07
-$22.36M
derived: sum of 4 quarters · filed 2017-09-07
2015-09-30-$5.88M
10-Q · filed 2016-11-07
-$11.17M
derived: sum of 2 quarters · filed 2017-09-07
-$18.40M
derived: sum of 3 quarters · filed 2017-09-07
-$24.64M
derived: sum of 4 quarters · filed 2017-09-07
2015-06-30-$5.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07
-$12.52M
derived: sum of 2 quarters · filed 2017-09-07
-$18.77M
derived: sum of 3 quarters · filed 2017-09-07
-$24.68M
10-K · filed 2017-09-07
2015-03-31-$7.23M
10-Q · filed 2016-05-09
-$13.47M
derived: sum of 2 quarters · filed 2016-05-09
-$19.38M
10-Q · filed 2016-05-09
-$25.58M
derived: sum of 4 quarters · filed 2016-09-07
2014-12-31-$6.25M
10-Q · filed 2016-02-08
-$12.16M
10-Q · filed 2016-02-08
-$18.35M
derived: sum of 3 quarters · filed 2016-09-07
-$27.63M
derived: sum of 4 quarters · filed 2016-09-07
2014-09-30-$5.91M
10-Q · filed 2015-11-05
-$12.11M
derived: sum of 2 quarters · filed 2016-09-07
-$21.38M
derived: sum of 3 quarters · filed 2016-09-07
-$28.09M
derived: sum of 4 quarters · filed 2016-09-07
2014-06-30-$6.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07
-$15.47M
derived: sum of 2 quarters · filed 2016-09-07
-$22.18M
derived: sum of 3 quarters · filed 2016-09-07
-$26.93M
10-K · filed 2016-09-07
2014-03-31-$9.28M
10-Q · filed 2015-05-06
-$15.98M
derived: sum of 2 quarters · filed 2015-05-06
-$20.74M
10-Q · filed 2015-05-06
-$27.73M
derived: sum of 4 quarters · filed 2015-09-09
2013-12-31-$6.71M
10-Q · filed 2015-02-05
-$11.46M
10-Q · filed 2015-02-05
-$18.45M
derived: sum of 3 quarters · filed 2015-09-09
-$24.13M
derived: sum of 4 quarters · filed 2015-09-09
2013-09-30-$4.75M
10-Q · filed 2014-11-06
-$11.74M
derived: sum of 2 quarters · filed 2015-09-09
-$17.43M
derived: sum of 3 quarters · filed 2015-09-09
-$21.91M
derived: sum of 4 quarters · filed 2015-09-09
2013-06-30-$6.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09
-$12.67M
derived: sum of 2 quarters · filed 2015-09-09
-$17.16M
derived: sum of 3 quarters · filed 2015-09-09
-$21.16M
10-K · filed 2015-09-09
2013-03-31-$5.68M
10-Q · filed 2014-05-08
-$10.17M
derived: sum of 2 quarters · filed 2014-05-08
-$14.16M
10-Q · filed 2014-05-08
-$18.30M
derived: sum of 4 quarters · filed 2014-05-08
2012-12-31-$4.49M
10-Q · filed 2014-02-05
-$4.49K
10-Q · filed 2013-01-31
-$8.48M
10-Q · filed 2014-02-05
-$8.48K
10-Q · filed 2013-01-31
-$12.62M
derived: sum of 3 quarters · filed 2014-02-05
-$16.79M
derived: sum of 4 quarters · filed 2014-02-05
2012-09-30-$4.00M
10-Q · filed 2013-11-05
-$8.13M
derived: sum of 2 quarters · filed 2013-11-05
-$12.30M
derived: sum of 3 quarters · filed 2013-11-05
-$12.31M
derived: sum of 4 quarters · filed 2013-11-05
2012-06-30-$4.13M
10-K · filed 2012-09-10
-$8.31M
derived: sum of 2 quarters · filed 2013-05-08
-$8.31M
derived: sum of 3 quarters · filed 2013-05-08
-$14.79M
10-K · filed 2014-09-11
2012-03-31-$4.17M
10-Q · filed 2013-05-08
-$4.18M
derived: sum of 2 quarters · filed 2013-05-08
-$10.66M
10-Q · filed 2013-05-08
-$12.39M
derived: sum of 4 quarters · filed 2013-05-08
2011-12-31-$1.99K
10-Q · filed 2013-01-31
-$1.99M
10-Q · filed 2012-02-09
-$6.49K
10-Q · filed 2013-01-31
-$6.49M
10-Q · filed 2012-02-09
-$8.22M
derived: sum of 3 quarters · filed 2013-01-31
-$10.83M
derived: sum of 4 quarters · filed 2013-01-31
2011-09-30-$4.49M
10-Q · filed 2012-11-06
-$8.22M
derived: sum of 2 quarters · filed 2012-11-06
-$10.83M
derived: sum of 3 quarters · filed 2012-11-06
-$13.65M
derived: sum of 4 quarters · filed 2012-11-06
2011-06-30-$3.73M
10-K · filed 2012-09-10
-$6.34M
derived: sum of 2 quarters · filed 2012-09-10
-$9.16M
derived: sum of 3 quarters · filed 2012-09-10
-$10.85M
10-K · filed 2013-09-11
2011-03-31-$2.61M
10-K · filed 2012-09-10
-$5.43M
derived: sum of 2 quarters · filed 2012-09-10
-$7.12M
10-Q · filed 2012-05-08
2010-12-31-$2.82M
10-K · filed 2012-09-10
-$4.51M
10-Q · filed 2012-02-09
2010-09-30-$1.69M
10-K · filed 2012-09-10
2010-06-30-$7.45M
10-K · filed 2012-09-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Passage BIO, Inc. (PASG)United States$0.015B-0.43
IN8BIO, INC. (INAB)United States$0.012B-0.76
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B